 Provider News OhioDecember 2023 Provider Newsletter Contents
OHBCBS-CDCRCM-045278-23 HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). 
What are three things everyone should know about you?I love Disney! The magic of Disney brings so much happiness to my life and inspiration to me. As Walt Disney said, “All our dreams can come true, if we have the courage to pursue them.” This quote is in my back pocket every day for my career growth. Fun fact, I watch at least one Disney movie a day as well as I have two babies named Luke and Leia! I am very driven about my job at Anthem Blue Cross and Blue Shield (Anthem). My professional surroundings would say I absorb like a sponge. Every day, I learn something new and use it to my advantage to help providers, coworkers, or career advancement. Anthem has been so rewarding to me and has given me a whole new perspective for members as well as providers. I am very passionate about animals. If I could, I would save every animal in the world! I have seven animals: three dogs and four cats, and each of them having their own little personality and bring so much joy and laughter to me. What is one thing you never leave home without?I never leave home without my phone. My phone is my source of communication and has air drop, which allows my husband and me to share our locations. My phone has apple pay, which is essentially a virtual debit/credit card and has my home alarms and camera linked and in case of an emergency it has my contacts and personal health information. Who has been most influential in your life?My aunt has been the most influential person in my life. She has been a guiding light to my life and has helped shape me to be the woman I am today. Many folks will say I resemble my grandma, who raised her. My grandma passed when I was a young child, but I believe my aunt is the angel of her. My aunt is extremely driven, passionate, and always sees the good in an individual, which has embraced me to always take the best route in life. When I need a shoulder to cry on, a laugh to share, or someone’s company, she’s always the person that comes to mind. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-044088-23 Effective for claims processed on or after December 1, 2023, the editing systems at Anthem Blue Cross and Blue Shield will be updated to align with the American Medical Association (AMA) CPT® Manual, HPCPS Level II Manual, and Centers for Medicare & Medicaid Services (CMS) correct coding guidelines, for the following services: Ulcer debridement and ulcer staging:- According to the ICD-10 Diagnosis Coding Manual, specific diagnosis codes that reflect the stage of the ulcer should be billed with the appropriate CPT code. For example, if billing a stage 3 pressure ulcer code, a stage 4 diagnosis code should not be reported.
- According to the AMA CPT Manual, a debridement of an ulcer should be reported with the appropriate diagnosis code that reflects that service.
Billing of anatomical modifiers:- According to the AMA CPT and HCPCS Level II manuals, the appropriate anatomical modifier is required to be appended to the appropriate procedure code. If not, the claim line will be denied. These modifiers designate the body part that a service is being performed on (for example, FA: Left hand, thumb, TA: Left foot, great toe).
Billing of interprofessional telephone/internet consultations:- These billed procedure codes will follow the AMA CPT Manual coding guidelines.
Claim lines not billed in accordance with the correct coding guidance outlined above will be denied. If you disagree with a claim reimbursement decision, please follow the claim dispute process (including submission of such documentation with the dispute) as outlined in the Provider Manual. If you have questions about this communication or need assistance with any other item, contact your provider relationship management representative. With your help, we can continually build towards a future of shared success. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-038660-23, MULTI-BCBS-CR-046278-23-CPN45683 In 2024, the annual PCP Access Studies Office Level Survey will be performed by a new vendor, the Center for the Study of Services (CSS). The purpose of this survey is to assess adequate appointment wait times for our members with an urgent condition or for routine services. The survey will be conducted in the same manner as in the past, and your cooperation is expected and appreciated. Kindly notify office staff of the requirement to participate in this survey. Keeping your data up to date is a condition of your provider contract with Anthem Blue Cross and Blue Shield (Anthem) and a requirement as part of the Consolidated Appropriations Act (CAA). We ask that you update office information using the PDM application on the Availity Essentials platform and that you participate in quality programs such as this critical survey. Office information crucial for the survey includes: - Having correct, working phone numbers.
- Updating information such as when a practitioner has moved, retired, or is deceased.
- Updating if your practice is no longer contracted with Anthem, accepts private pay only, or is no longer in business.
You are also required to provide compliant after-hours, 24/7, urgent care messaging, instructing the caller/patient to hang up and call 911 or go to urgent care or emergency room (ER) or you must directly connect the caller with PCP or on-call physician. Your contract compels access for all covered members to obtain timely needed appointments. The leading timeframes are below. Ohio Primary care appointment access | Urgent appointment | Within 24 hours | Routine appointment | Within 10 business days | Routine/follow-up appointment Evaluate progress from today’s visit | Within 30 calendar days | Preventive care appointment | Within 30 calendar days | See your Anthem Blue Cross and Blue Shield Provider Manual for details |
Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CM-044766-23-CPN44728 The annual behavioral health access studies will see a change in 2024 as a new vendor, Center for the Study of Services (CSS) in Washington, D.C., will be performing the office level survey and making calls during the first through third quarters. The survey will be conducted in the same manner as in the past and your cooperation is expected and appreciated. The purpose is to assess adequate appointment wait times for our members with an urgent condition or for routine services. Consequently, we ask that you update office information using the PDM application on Availity Essentials or follow processes if assigned to Carelon Behavioral Health, Inc., and that you participate in quality programs, such as this critical survey, as a condition of your contract. The main challenges the vendor encounters are incorrect or non-working phone numbers; practitioner moved, retired, or is deceased; the practice has left their Anthem Blue Cross and Blue Shield (Anthem) contract, accepts private pay only, or is no longer in practice; and staff refusing to participate in the survey. Please take time to update information for each practitioner associated with the practice phone number(s), past or present. Your contract compels access for all covered individuals to obtain timely needed appointments. The leading timeframes are below. See your Anthem Provider Manual for details. And don’t forget your compliant after-hours emergency or urgent messaging 24/7, by a recording or a live person, instructing the caller/patient to hang up and call 911 or 24-hour crisis services, or go to urgent care or ER; or directly connecting with practitioner or on-call practitioner. Ohio behavioral healthcare appointment accessEmergent — non-life threatening | Within six hours | Urgent appointment | Within 24 hours | Discharge follow-up BH appointment (new or existing patient — inpatient psychiatric hospital release) | Within seven calendar days | Routine — initial appointment (new patient) | Within 10 business days | Routine — regular appointment | Within 10 business days | Routine — follow-up appointment (evaluate progress from today’s visit) | Within 30 calendar days |
We are committed to helping patients more easily access the care they need. Carelon Behavioral Health, Inc. is an independent company providing utilization management services on behalf of the health plan. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CM-044751-23-CPN44731 As a reminder, we will update our claim editing software for outpatient facility services throughout 2024, with many updates occurring quarterly. These updates include, but are not limited to: - The addition of new and revised codes (for example, CPT®, HCPCS, ICD-10, modifiers, revenue codes) and associated edits.
- Updates related to the appropriate use of various code combinations, including but not limited to, CPT/HCPCS code to revenue code, type of bill to procedure code, type of bill to CPT/HCPCS code, and CPT/HCPCS code to modifier.
- Updates to National Correct Coding Initiative edits (NCCI) and facility outpatient hospital services medically unlikely edits (MUEs).
- Updates to reflect coding requirements as designated by industry standard sources such as the National Uniform Billing Committee (NUBC) and the Centers for Medicare and Medicaid Services (CMS).
Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-044221-23-CPN44078 As a reminder, we will update our claim editing software for professional services throughout 2024, with most updates occurring quarterly. These updates apply to any provider, provider group (identified by tax identification number), and/or across providers and claim type (such as, professional or facility) and include, but are not limited to: - The addition of new, and revised codes (for example, CPT®, HCPCS, ICD-10, modifiers) and associated edits such as:
- ICD-10 laterality
- Add-on procedures (indicated by + sign)
- Code book parenthetical statements and other directives about appropriate code use (for example, separate procedure, do not report, list separately in addition to, etc.)
- Updates to editing for multiple procedure and bilateral reduction calculations based on relative value unit (RVU) as designated and updated by the Centers for Medicare & Medicaid (CMS) in the physician fee schedule relative value (PFSRV) files
- Updates to National Correct Coding Initiative edits (NCCI) and medically unlikely edits (MUEs)
- Updates to incidental, mutually exclusive, and unbundled (re-bundle) edits
- Updates to code edits associated with reimbursement policies including, but not limited to, bundled services, global surgery preoperative, and post-operative periods assigned by CMS, edits that allow/disallow for assistant surgeon/co-surgeon/team surgeon, and frequency edits.
Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-044218-23-CPN44074 Our utilization management (UM) decisions are based on the appropriateness of care and service needed, as well as the member’s coverage according to their health plan. We do not reward providers or other individuals for issuing denials of coverage, service, or care, nor do we make decisions about hiring, promoting, or terminating these individuals based on the idea or thought that they will deny benefits. In addition, we do not offer financial incentives for UM decision makers to encourage decisions resulting in under-utilization. The Anthem Blue Cross and Blue Shield (Anthem) Medical Policies are available on Anthem’s website at Anthem.com. You can also request a free copy of our UM criteria from our medical management department, and providers may discuss a UM denial decision with a physician reviewer by calling us at the toll-free numbers listed below. UM criteria are also available on the web. Just go to Anthem.com, and select For Providers > Provider Resources > Policies, Guidelines and Manuals > Select your state > View Medical Policies and Clinical UM Guidelines. We work with providers to answer questions about the utilization management process and the authorization of care. Here’s how the process works: - Call us toll free from 8:30 a.m. to 5 p.m. Monday through Friday (except on holidays). More hours may be available in your area. Federal Employee Program® hours are 8 a.m. to 7 p.m. Eastern.
- Our associates will contact you about your UM inquiries during business hours, unless otherwise agreed upon.
The following phone lines are for physicians and their staff. Members should call the customer service number on their health plan ID card. 
For language assistance, members can simply call the Customer Service phone number on the back of their ID card, and a representative will be able to assist them. Our utilization management associates identify themselves to all callers by first name, title, and our company name when making or returning calls. They can inform you about specific utilization management requirements, operational review procedures, and discuss utilization management decisions with you. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CM-044444-23-CPN44382 Administrative | Commercial | December 1, 2023 Notice of Material Amendments to Contract and/or Change to Prior Authorization Requirements Notification about submitting itemized billsOne of the greatest responsibilities Anthem Blue Cross and Blue Shield (Anthem) has to our members is to administer their benefits accurately. We conduct prepay itemized bill reviews for inpatient and outpatient services to ensure member cost shares are correctly applied. We have recently made the determination that our members would be best served if we were to require itemized bills for inpatient services billed in excess of $50,000 and outpatient services billed in excess of $20,000. On August 1, 2023, we implemented the following change when submitting itemized bills for Anthem inpatient and outpatient member claims for fully insured members only: - For inpatient services, submit an itemized bill for member claims in excess of $50,000.
- For outpatient services, submit an itemized bill for member claims in excess of $20,000.
- The itemized bill should be equal to the amount billed in order for us to process the claim.
Effective March 1, 2024, this change will also apply ASO (administrative services only) and BlueCard member claims. We want to reduce the impact to your billing area as much as possible, so we have introduced a process that will:- Reduce the time needed to identify a fully insured member.
- Eliminate the need to submit itemized bills when not needed.
- Integrate with your existing workflows to enable digital submission.
Anthem’s Digital Request for Additional Information (Digital RFAI) process enables you to submit itemized bills digitally through Availity.com. The most efficient way to submit itemized bills is through the Digital RFAI process. This is how it works:- Register for the Medical Attachments application on Availity.com.
- Submit your claim through either EDI or the Availity.com Claims & Payments application.
- If an itemized bill is needed, we send a notification to your Attachments Dashboard on Availity.com each morning by 8 a.m. Eastern.
- You retrieve the notification and upload the itemized bill directly to your claim as an attachment.
If an itemized bill is not required for the claim, you will not receive a notification, and the claim will continue through processing. Another benefit of the Digital RFAI process is the claim will pend (rather than deny), allowing up to 30 days for you to supply the requested itemized bill. Access the Digital RFAI webpage for learning resources, pre-recorded demonstrations, and more: - Start by viewing the Digital Request for Additional Information Training session.
- For help with Availity Medical Attachment setup, access this video for additional instructions.
- Not registered with Availity Essentials? Here’s a link to get started with Availity.
For more information, contact Availity Essentials Client Services at 800-282-4548 or use this link to take an on-demand Digital RFAI learning session Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-043843-23-CPN43763 Administrative | Commercial / Medicare Advantage | December 1, 2023 Notice of Material Amendments to Contract and/or Change to Prior Authorization Requirements New requirements for credentialing and recredentialingThe National Committee on Quality Assurance (NCQA) has advised Durable Medical Equipment (DME) providers are to be considered within the scope of an entity’s credentialing program for accreditation purposes. Starting February 2024, recredentialing of the existing Durable Medical Equipment Providers and Prosthetic and Orthotic Suppliers (DMEPOS) network will begin. You will receive communication asking you to either complete an application or to supply us with any of the following information: - Copy of all federal, state, and/or local licenses required to operate as a healthcare facility (by location).
- Copy of accreditation certificate or letters if accredited.
- Copy of most recent CMS or state survey (with deficiencies) including cover letter from CMS or state agency stating facility is in substantial compliance or Corrective Action Plan if deficiencies were cited if not accredited is required.
Please respond to these communications as quickly as possible so no disruption in service to our members or to you occurs. Contact information for questions related to this change will be included in the outreach sent. Through genuine collaboration, we can simplify access to care and help you deliver high-quality, equitable healthcare. The Credentialing team looks forward to working with you. What if I need assistance?If you have questions about this communication or need assistance with any other item, contact your local Provider Relationship Management representative or refer providers to the number on the back of their patient’s member ID card for Provider Services. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CRCM-041415-23-CPN39398 Coordination of care among providers is a vital aspect of good treatment planning to ensure appropriate diagnosis, treatment, and referral. Anthem Blue Cross and Blue Shield (Anthem) would like to take this opportunity to stress the importance of communicating with your patient’s other healthcare practitioners. This includes primary care physicians (PCPs) and medical specialists, as well as behavioral health practitioners (BH). Coordination of care is especially important for patients with high utilization of general medical services and those referred to a BH specialist by another healthcare practitioner. Anthem urges all of its practitioners to obtain the appropriate permission from these patients to coordinate care between BH and other healthcare practitioners at the time treatment begins. We expect all healthcare practitioners to: - Discuss with the patient the importance of communicating with other treating practitioners.
- Obtain a signed release from the patient and file a copy in the medical record:
- Document in the medical record if the patient refuses to sign a release.
- Document in the medical record if you request a consultation.
- If you make a referral, transmit necessary information; and if you are furnishing a referral, report appropriate information back to the referring practitioner.
- Document evidence of clinical feedback (in other words, consultation report) that includes, but is not limited to:
- Diagnosis
- Treatment plan
- Referrals
- Psychopharmacological medication (as applicable)
To facilitate coordination of care, we have several tools available on our Provider website for BH and other medical practitioners including: - Coordination of Care Form
- Coordination of Care Letter Template - Behavioral Health
- Coordination of Care Letter Template - Medical
The following behavioral health forms, brochures, and screening tools for substance use and attention-deficit/hyperactivity disorder (ADHD) are also available on our Provider website: - Alcohol Use Assessment Brochure
- Antidepressant Medication Management
- Edinburgh Postnatal Depression Scale
- Opioid Use Assessment Brochure
- Substance Brief Intervention/Referral Tool (SBIRT)
- Vanderbilt ADHD Diagnostic Parent Rating Scale
Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-044475-23-CPN44372 Managing any illness can be a difficult thing to do. Knowing who to contact, what test results mean, or how to get needed resources is very important and can be overwhelming. Anthem Blue Cross and Blue Shield (Anthem) is available to help with our Case Management Program. Our case managers are part of an interdisciplinary team of clinicians and professionals that are here to support members, families, primary care physicians, behavioral health practitioners, and caregivers. The case management process uses the experience and expertise of the care coordination team whose goal is to educate and empower our members to increase self-management skills, understand their illness, and learn about care choices in order to access quality, efficient healthcare. For physical health services, members or caregivers can refer themselves or family members by calling the number located below. They will be transferred to a team member based on their immediate need. Physicians can also refer their patients by contacting us telephonically or through electronic means. No issue is too big or too small. We can help with transitions across level of care so members and caregivers are better prepared and informed about healthcare decisions and goals. For BH or substance use disorder services members can contact their health plan to verify benefits and access Anthem.com, or if an FEP member, fepblue.com to search for and access BH providers. It is best to have the member or member’s family contact our department directly to ensure privacy. How do you contact us?For commercial and exchange members, the member can contact customer service for assistance. For FEP members, physical and behavioral health practitioners can refer to Anthem behavioral health case management with member consent by calling 800-711-2225 option 3. | Email address (if available) | Phone number | Business hours | Ohio | care.management@anthem.com | 888-662-0939 866-962-1214 800-831-7161 | Monday-Friday, 8 a.m. to 7 p.m. ET | FEP | FEP_PPO_Case_Mgmt@blueshieldca.com | 800-995-2800 | Monday-Friday, 8 a.m.-7 p.m. PT |
Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CM-044870-23-CPN44375 We ask that you review your online provider directory information on a regular basis to ensure it is accurate. Access your information by visiting anthem.com/provider, then select the Find Care button at the top right of the webpage. Submit updates and corrections to your directory information by following the instructions on our Provider Maintenance webpage. We will send you an email acknowledging receipt of your request. Online update options include: - Add/change an address location
- Name change
- Phone/fax number change
- Provider leaving a group or a single location
- Closing a practice location
The Consolidated Appropriations Act (CAA) of 2021 contains a provision that requires online provider directory information be reviewed and updated as needed at least every 90 days. Reviewing your information on a regular basis is the best way to help ensure your online provider directory information is current. With your help, we can continually build towards a future of shared success. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-044661-23-CPN44642 As part of our commitment to provide you with the latest clinical information and educational materials, we have adopted nationally recognized medical, behavioral health and preventive health guidelines, which are available to providers on our website. The guidelines, which are used for our quality programs, are based on reasonable medical evidence, and are reviewed for content accuracy, current primary sources, the newest technological advances, and recent medical research. All guidelines are reviewed annually and updated as needed. The current guidelines are available on our website at https://www.anthem.com/provider/ and select Change State >Provider > Select Policies, Guidelines & Manuals under Provider Resources> scroll down and select Clinical Practice Guidelines or Preventive Health Guidelines. If you have questions, please contact the number on the back of the member ID card for Provider Services. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-044458-23-CPN44378 The delivery of quality healthcare requires cooperation between patients, their providers, and their healthcare benefit plans. One of the first steps is for patients and providers to understand their rights and responsibilities. Therefore, in line with our commitment to involve the health plan, participating practitioners, and members in our system, Anthem Blue Cross and Blue Shield has adopted a Members’ Rights and Responsibilities statement. This statement can be found on our website under the FAQ question about Laws and Rights that Protect You. To access the statement, visit anthem.com and select Provider. From there, select Policies, Guidelines & Manuals under Provider Resources. Select your state and scroll down to Member Rights and Responsibilities under More Resources. Then select the Read about member rights link. For federal employees, practitioners may access the FEP member portal at www.fepblue.org/memberrights to view the FEPDO Member Rights Statement. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-044468-23-CPN44377 A new way to review Medical Policies and Utilization Management (UM) Guidelines for needed documentationUsing Medical Policies and UM Guidelines, we’ve developed a tool that supplies you with a list of recommended documents when submitting prior authorizations or claims. The new Clinical Documentation Lookup Tool uses the CPT® and HCPCS codes you enter to return real-time results. Accessing the tool is easy, too — either by visiting our provider website (access the Clinical Documentation Lookup Tool from our Policies, Guidelines & Manuals section) or through Payer Spaces on Availity.com. For direct access, use this address (available mid-December) https://clinicaldocumentationtool.anthem.com/cdltui/home. Start by entering in the member’s plan type, state, and service dates. Enter the Procedure Code or use the Keyword Search box. The recommended documents will be returned along with a full copy of the Medical Policy. The Clinical Documentation Lookup Tool was developed to be intuitive and easy to use, but we’ve created a demonstration that points out some helpful tips. Access the demo from the top right navigation bar on the Clinical Documentation Lookup Tool. The new Clinical Documentation Lookup Tool will be available in December. Try it and tell us what you think by completing the Was this tool helpful? question. We are focused on reducing administrative burdens, so you can do what you do best — care for our members. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-045315-23-CPN44857 Carelon Post Acute Solutions, LLC redirectionEffective immediately, Carelon Post Acute Solutions requests (Skilled Nursing Facilities, Acute Inpatient Rehab, and Long-Term Acute Care) that are sent to Anthem Blue Cross and Blue Shield in error will be canceled. Providers will then be notified either verbally or through Availity of the cancellation and redirected to use Carelon Post Acute Solutions using NexLync, the Carelon Post Acute Solutions provider website at https://portal.mynexuscare.com. Providers can also upload clinical information and check requests 24/7 via NexLync, or they can call the Carelon Post Acute Solutions provider call center at 833-431-0780. Note: Certain members may not be included on Availity. Please contact customer service for additional information if you are unable get a decision on Availity. Availity Essentials clinical denial/approval outcome notification processEffective immediately, providers will receive clinical denial/approval notifications for cases received via Availity through the Availity Essentials notification in lieu of verbal communication. Providers will continue to receive notification letters via fax and conventional mail as applicable. We are focused on reducing administrative burdens, so you can do what you do best — care for our members. Carelon Post Acute Solutions, LLC is an independent company providing services on behalf of the health plan. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-040820-23 When you have more information to share about a claim that has been denied, filing the dispute digitally is a cost-effective and time-saving alternative to paper and fax. You can feel confident that we have received your claims dispute when you submit it through the digital workflow. This Claim Status application feature, available on Availity.com, enables a fast, efficient, and streamlined process for filing claim disputes: - Upload supporting documentation and attach it directly to the claim.
- Use the Appeals Dashboard:
- To review digitally filed disputes.
- To retrieve correspondence related to your disputes.
- For a history of digitally filed disputes.
How to file a digital claim payment dispute:- Log onto Availity.com.
- Select the Claims & Payments tab.
- Select Claim Status and enter the information needed to retrieve your claim.
- When you have found your claim, select the Dispute button to initiate a dispute (it will be visible when your claim is eligible for a dispute).
- Access your Appeals Dashboard to upload the supporting documents, locate initiated dispute, and complete the dispute request:
- From the Claims & Payments tab select Appeals to access your Appeals Dashboard.
In the past, you may have used the Attachment button and selected the Dispute option to dispute a claim. We’ve eliminated that process to make disputing a claim more trackable and transparent. 
Receive dispute determinations digitally from your Appeals DashboardWe will review the dispute and communicate an outcome on Availity.com. Check the status of a digitally submitted dispute at any time from your Appeals Dashboard. Learn moreSubmitting a digital claim payment dispute is easy, but attending informative learning sessions provides a deep dive into the application and its search and filter functions. These tips are sure to make the submission process even easier. Use this link to access on-demand training. For more information about the claim payment dispute process, consult the provider manual or reach out to your provider relationship management representative. OHBCBS-CD-041335-23-CPN41106 As a contracted provider for special needs plan (SNP) from Anthem Blue Cross (Anthem), you are required to participate in an annual model of care training for providers per CMS regulations. This training includes a detailed overview of Anthem special needs plans and program information — highlighting cost sharing, data sharing, participation in the Interdisciplinary Care team (ICT), where to access the member’s health risk assessment results, plan of care, and benefit coordination. Please remember this training is specific to our plans and delivery of care for members ensuring their specific care needs are met. Your participation is critical for improved quality and health outcomes. Training for SNP product for Anthem is self-paced and available at availity.com. The training must be completed by December 31, 2023. How to access the Custom Learning Center on the Availity Essentials website:- Log in to Availity Essentials website at availity.com:
- At the top of Availity Essentials website, select Payer Spaces and select the appropriate payer.
- On the Payer Spaces landing page, select Access Your Custom Learning Center from Applications.
- In the Custom Learning Center, select Required Training.
- Select Special Needs Plan and Model of Care Overview.
- Select Enroll.
- Select Start.
- Once the course is completed, select Begin Attestation and complete.
Not registered for Availity Essentials?Have your organization’s designated administrator register your organization for the Availity Essentials website: - Visit availity.com to register.
- Select Register.
- Select your organization type.
- In the Registration wizard, follow the prompts to complete the registration for your organization.
Refer to these PDF documents: https://apps.availity.com/availity/Demos/Registration/index.htm for complete registration instructions. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-044322-23-CPN44315 The Medical Policies, Clinical Utilization Management (UM) Guidelines, and Third-Party Criteria below were developed and/or revised to support clinical coding edits. Note, several policies and guidelines were revised to provide clarification only and are not included. Existing precertification requirements have not changed. Please share this notice with other providers in your practice and office staff. To view a guideline, visit Medicare Advantage Providers | Anthem.com and select Change State. Then select your state > Providers > Policies, Guidelines & Manuals. Notes/updatesUpdates marked with an asterisk (*) notate that the criteria may be perceived as more restrictive. - MED.00004 – Noninvasive Imaging Technologies for the Evaluation of Skin Lesions; Previously Titled: Technologies for the Evaluation of Skin Lesions (including Dermatoscopy, Epiluminescence Microscopy, Videomicroscopy and Ultrasonography):
- Revised title
- Added additional technologies to Investigational & Not Medically Necessary section.
- SURG.00161 – Nanoparticle-Mediated Thermal Ablation:
- Nanoparticle-mediated thermal ablation is considered Investigational & Not Medically Necessary for all indications
- CG-ANC-06 – Ambulance Services: Ground; Non-Emergent:
- Revised Medically Necessary and Not Medically Necessary statements regarding mileage.
- Revised Not Medically Necessary statement to remove list of non-covered indications.
- CG-LAB-29 – Gamma Glutamyl Transferase Testing:
- Outlines the Medically Necessary and Not Medically Necessary criteria for laboratory testing of gamma glutamyl transferase (GGT) in blood.
- CG-LAB-30 – Outpatient Laboratory-based Blood Glucose Testing:
- Outlines the Medically Necessary and Not Medically Necessary criteria for laboratory testing to determine blood glucose concentration.
- CG-SURG-95 – Sacral Nerve Stimulation and Percutaneous or Implantable Tibial Nerve Stimulation for Urinary and Fecal Incontinence; Urinary Retention; Previously Titled: Sacral Nerve Stimulation and Percutaneous Tibial Nerve Stimulation for Urinary and Fecal Incontinence, Urinary Retention:
- Revised title
- Added Medically Necessary criteria for temporary SNS for urinary and fecal conditions.
- Reformatted Medically Necessary criteria for permanent SNS for urinary and fecal conditions.
- Revised the Clinical Indications section IV for percutaneous or implantable tibial nerve stimulation (PTNS) to include implantable devices.
Medical Policies On May 11, 2023, the Medical Policy and Technology Assessment Committee (MPTAC) approved the following Medical Policies applicable to Anthem Blue Cross and Blue Shield (Anthem). These medical policies take effect December 27, 2023. Publish date | Medical Policy number | Medical Policy title | New or revised | 5/25/2023 | GENE.00052 | Whole Genome Sequencing, Whole Exome Sequencing, Gene Panels, and Molecular Profiling | Revised | 6/28/2023 | *MED.00004 | Noninvasive Imaging Technologies for the Evaluation of Skin Lesions Previously Titled: Technologies for the Evaluation of Skin Lesions (including Dermatoscopy, Epiluminescence Microscopy, Videomicroscopy and Ultrasonography) | Revised | 7/18/2023 | MED.00135 | Gene Therapy for Hemophilia | Revised | 5/25/2023 | SURG.00121 | Transcatheter Heart Valve Procedures | Revised | 6/28/2023 | *SURG.00161 | Nanoparticle-Mediated Thermal Ablation | New | 6/28/2023 | TRANS.00025 | Laboratory Testing as an Aid in the Diagnosis of Heart Transplant Rejection | Revised |
Clinical UM Guidelines On May 11, 2023, the MPTAC approved the following Clinical UM Guidelines applicable to Anthem. These guidelines were adopted by the medical operations committee for Medicare members on June 22, 2023. These guidelines take effect December 27, 2023. Publish date | Clinical UM Guideline number | Clinical UM Guideline title | New or revised | 6/28/2023 | *CG-ANC-06 | Ambulance Services: Ground; Non-Emergent | Revised | 6/28/2023 | CG-DME-31 | Powered Wheeled Mobility Devices | Revised | 6/28/2023 | CG-DME-36 | Pediatric Gait Trainers | Revised | 6/28/2023 | CG-DME-42 | Continuous Glucose Monitoring Devices and External Insulin Infusion Pumps | Revised | 6/28/2023 | CG-GENE-16 | BRCA Genetic Testing | Revised | 6/28/2023 | CG-GENE-22 | Gene Expression Profiling for Managing Breast Cancer Treatment | Revised | 5/25/2023 | CG-LAB-22 | Nucleic Acid Amplification Tests Using Algorithmic Analysis for the Diagnosis of Vaginitis Previously Titled: Nucleic Acid Amplification Tests Using Algorithmic Analysis for the Diagnosis of Bacterial Vaginosis | Revised | 6/28/2023 | CG-LAB-25 | Outpatient Glycated Hemoglobin and Protein Testing | Revised | 6/28/2023 | *CG-LAB-29 | Gamma Glutamyl Transferase Testing | New | 6/28/2023 | *CG-LAB-30 | Outpatient Laboratory-based Blood Glucose Testing | New | 6/28/2023 | CG-MED-59 | Upper Gastrointestinal Endoscopy in Adults | Revised | 6/28/2023 | CG-MED-66 | Cryopreservation of Oocytes or Ovarian Tissue | Revised | 6/28/2023 | CG-SURG-101 | Ablative Techniques as a Treatment for Barrett's Esophagus | Revised | 5/25/2023 | CG-SURG-115 | Mechanical Embolectomy for Treatment of Stroke | Revised | 6/28/2023 | CG-SURG-61 | Cryosurgical, Radiofrequency or Laser Ablation to Treat Solid Tumors Outside the Liver | Revised | 6/28/2023 | CG-SURG-78 | Locoregional Techniques for Treating Primary and Metastatic Liver Malignancies Previously Titled: Locoregional and Surgical Techniques for Treating Primary and Metastatic Liver Malignancies | Revised | 6/22/2023 | CG-SURG-81 | Cochlear Implants and Auditory Brainstem Implants | Revised | 6/28/2023 | *CG-SURG-95 | Sacral Nerve Stimulation and Percutaneous or Implantable Tibial Nerve Stimulation for Urinary and Fecal Incontinence; Urinary Retention Previously Titled: Sacral Nerve Stimulation and Percutaneous Tibial Nerve Stimulation for Urinary and Fecal Incontinence, Urinary Retention | Revised |
Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-043577-23-CPN42042 Medical Policy & Clinical Guidelines | Commercial | December 1, 2023 Notice of Material Amendments to Contract and/or Change to Prior Authorization Requirements Medical Policies and Clinical Guidelines updates — December 2023The following Anthem Blue Cross and Blue Shield (Anthem) Medical Polices and Clinical Guidelines were reviewed for Indiana, Kentucky, Missouri, Ohio, and Wisconsin. To view Medical Policies and Utilization Management Guidelines, go to anthem.com > select Providers > select your state > under Provider Resources > select Policies, Guidelines & Manuals. To help determine if prior authorization is needed for Anthem members, go to anthem.com > select Providers > select your state > under Claims > select Prior Authorization. You can also call the prior authorization phone number on the back of the member’s ID card. To view Medical Policies and Clinical Utilization Management Guidelines applicable to members enrolled in the Blue Cross and Blue Shield Service Benefit Plan (commonly referred to as the Federal Employee Program® [FEP®]), please visit fepblue.org > Policies & Guidelines. With your help, we can continually build towards a future of shared success. Below are the new medical policies and/or clinical guidelines that have been approved. * Denotes prior authorization required Policy/guideline | Information | Effective date | TRANS.00041 Histological Analysis using Microarray Gene Expression Profiling for Kidney Allograft Injury or Rejection | • Histological analysis using microarray gene expression profiling is considered INV&NMN for detection of allograft injury or rejection in kidney transplant recipients | 3/1/2024 | MED.00147 Cellular Therapy Products for Allogeneic Stem Cell Transplantation | • Outlines the MN and INV&NMN criteria for the use of ex-vivo expansion of cord blood stem cell products Existing ICD-10-PCS codes XW133C8, XW143C8 considered MN when criteria are met; no specific CPT/HCPCS codes for omidubicel, listed NOC codes 38999, C9399, J3490, J3590 | 3/1/2024 | MED.00144 Gene Therapy for Duchenne Muscular Dystrophy | • Outlines the MN and INV&NMN criteria for the infusion of Delandistrogene moxeparvovec-rokl (ELEVIDYS) No specific code for ELEVIDYS; listed NOC codes C9399, J3490, J3590 considered MN when criteria are met | 3/1/2024 |
Below are the current Clinical Guidelines and/or Medical Policies we reviewed, and updates were approved. * Denotes prior authorization required Policy/guideline | Information | Effective date | CG-SURG-107 Surgical and Minimally Invasive Treatments for Benign Prostatic Hyperplasia (BPH) | Will now use MCG Guideline for review: MCG- Urologic Surgery or Procedure GRG /GRG: W0141 (ISC GRG) (Codes 0421T; 0714T; 52441 52442, 52450, 52647, 52648, 52649; 53850, 53852, 53854; 55873, C2596, C9739; C9740, C9769 and associated ICD-10-PCS codes) | 12/1/2023 | CG-SURG-107 Surgical and Minimally Invasive Treatments for Benign Prostatic Hyperplasia (BPH) | Code 53855 Moving to pre-cert. Note: Will now use MCG Guideline for review: MCG- Urologic Surgery or Procedure GRG /GRG: W0141 (ISC GRG) | 3/1/2024 | SURG.00119 Endobronchial Valve Devices | Will now use MCG Guideline for review: Thoracic Surgery or Procedure GRG/ GRG: SG-TS (ISC GRG) (CPT® codes 31647, 31648, 31649, 31651 and associated ICD-10-PCS codes) | 12/1/2023 | *CG-SURG-27 Gender Affirming Surgery | Will now use MCG Guideline for review: Gender-Affirming Surgery or Procedure GRG:GG-FMMF (ISC GRG) (Codes: 11920, 11921, 11922, 19325, 19350, 56800, 56805, 57291, 57292, 19303, 19304, 54125, 54520, 54660, 54690, 55180, 55970, 56625, 57110, 57295, 57296, 57426, 58150, 58552, 58554, 58570, 58571, 58572, 58573 and associated ICD-10-PCS codes) | 12/1/2023 | MED.00122 Wilderness Programs | • MED.00122 will be archived • MCG BHG B-822-T will be used for review | 12/1/2023 | CG-MED-46 Electroencephalography and Video Electroencephalographic Monitoring | Added new ICD-10-CM diagnosis codes G40.C01-G40.C19 for seizures - Adding codes 95700, 95705-95706, 95709, 95711-95726 to pre-cert. | 3/1/2024 | CG-GENE-15 Genetic Testing for Lynch Syndrome, Familial Adenomatous Polyposis (FAP), Attenuated FAP and MYH-associated Polyposis | Added new ICD-10-CM diagnosis codes D13.91, D48.110-D48.119, Z83.710-Z83.719 effective 10/01/2023 replacing D48.1, Z83.71 | 9/27/2023 | TRANS.00004 Cell Transplantation (Mesencephalic, Adrenal-Brain and Fetal Xenograft) | Added new ICD-10-CM diagnosis codes G20.A1-G20.C for Parkinson's replacing G20 | 10/1/2023 | SURG.00150 Leadless Pacemaker | Added ICD-10-PCS X2H63V9, X2HK3V9 for dual chamber leadless pacemaker, considered INV&NMN | 9/27/2023 | SURG.00112 Implantation of Occipital, Supraorbital or Trigeminal Nerve Stimulation Devices (and Related Procedures) | Added new ICD-10-CM diagnosis codes G43.E01-G43.E19 for migraine (end of range) | 10/1/2023 | SURG.00096 Surgical and Ablative Treatments for Chronic Headaches | Added new ICD-10-CM diagnosis codes G43.E01-G43.E19 for migraine (end of range) | 10/1/2023 | SURG.00071 Percutaneous and Endoscopic Spinal Surgery | Added existing HCPCS outpatient code C2614 for probe considered INV&NMN | 3/1/2024 | SURG.00026 Deep Brain, Cortical, and Cerebellar Stimulation | Added existing HCPCS outpatient code C1787 for programming device considered MN when criteria are met; added new ICD-10-CM diagnosis codes G20.A1-G20.C for Parkinson's replacing G20 | 3/1/2024 | SURG.00011 Allogeneic, Xenographic, Synthetic, Bioengineered, and Composite Products for Wound Healing and Soft Tissue Grafting | Added new HCPCS codes A2022, A2023, A2024, A2025, Q4285, Q4286 for products considered INV&NMN; added existing code C1832 for Recell, considered INV&NMN | 3/1/2024 | MED.00145 Digital Therapy Devices for Treatment of Amblyopia | Added new HCPCS code A9292 for amblyopia software considered INV&NMN | 3/1/2024 | MED.00143 Ingestible Devices for the Treatment of Constipation | Added new HCPCS codes A9268, A9269 for Vibrant Gastro System capsule and programmer considered INV&NMN replacing NOC code | 3/1/2024 | MED.00125 Biofeedback and Neurofeedback | Added new ICD-10-CM diagnosis codes G43.E01-G43.E19 for migraine (end of range) | 10/1/2023 | LAB.00046 Testing for Biochemical Markers for Alzheimer's Disease | Added new CPT PLA code 0412U for PrecivityAD® blood test considered INV&NMN | 3/1/2024 | LAB.00041 Machine Learning Derived Probability Score for Rapid Kidney Function Decline | Added new CPT PLA code 0407U for IntelxDKD test, considered INV&NMN6 | 3/1/2024 | LAB.00016 Fecal Analysis in the Diagnosis of Intestinal Disorders | Added new ICD-10-CM codes K63.8211-K63.829 effective 10/01/2023 for intestinal microbial overgrowth | 10/1/2023 | GENE.00052 Whole Genome Sequencing, Whole Exome Sequencing, Gene Panels, and Molecular Profiling | Added existing CPT PLA code 0262U considered NMN; added new CPT PLA codes 0409U, 0414U (considered MN when criteria are met); 0405U (considered NMN); 0410U, 0413U, 0415U, 0417U (considered INV&NMN); Removed 0397U | 3/1/2024 | GENE.00010 Panel and other Multi-Gene Testing for Polymorphisms to Determine Drug-Metabolizer Status | Added new CPT PLA codes 0411U, 0419U considered INV&NMN | 3/1/2024 | GENE.00009 Gene Expression Profiling and Genomic Biomarker Tests for Prostate Cancer | Added new CPT PLA code 0403U effective 10/01/2023 for MyProstateScore 2.0 considered INV&NMN | 3/1/2024 | ANC.00008 Cosmetic and Reconstructive Services of the Head and Neck | Changed CPT code 15829 to Reconstructive when criteria are met (was COS&NMN) | 9/27/2023 | TRANS.00039 Portable Normothermic Organ Perfusion Systems | • Added MN criteria for portable normothermic heart perfusion • Reformatted MN criteria for lung and liver perfusion Added CPT Category III codes 0494T, 0495T, 0496T for lung perfusion (from TRANS.00009); added ICD-10-PCS codes 6ABB0BZ, 6AB50BZ, 6ABF0BZ, 6ABT0BZ | 3/1/2024 | TRANS.00009 Lung and Lobar Transplantation | Removed CPT Category III codes 0494T, 0495T, 0496T for lung perfusion (now addressed in TRANS.00039) | 9/27/2023 | TRANS.00035 Therapeutic use of Stem Cells, Blood and Bone Marrow Products | Added new ICD-10-CM diagnosis codes G20.A1-G20.C for Parkinson's replacing G20 | 10/1/2023 | SURG.00144 "Occipital and Sphenopalatine Ganglion Nerve Block Therapy for the Treatment of Headache and Neuralgia Previously titled: Occipital Nerve Block Therapy for the Treatment of Headache and Occipital Neuralgia " | • Revised title • Added INV&NMN statement for sphenopalatine ganglion nerve blocks Added existing CPT code 64505, considered INV&NMN for headache or occipital neuralgia; added new ICD-10-CM diagnosis codes G43.E01-G43.E19 for migraine (end of range) | 3/1/2024 | SURG.00129 Oral, Pharyngeal and Maxillofacial Surgical Treatment for Obstructive Sleep Apnea or Snoring | • Removed the criteria examples for failed CPAP treatment • Added definition for failed CPAP treatment | 9/27/2023 | SURG.00052 Percutaneous Vertebral Disc and Vertebral Endplate Procedures | • Added MN and NMN criteria for intraosseous basivertebral nerve ablation (BVNA) CPT and ICD-10-PCS codes 64628, 64629, 015B3ZZ, 015B4ZZ for BVNA considered MN when criteria are met (were INV&NMN) | 3/1/2024 | SURG.00007 Vagus Nerve Stimulation | • Removed INV&NMN example under implanted VNS for epilepsy and added stroke rehabilitation as an example • Removed all INV&NMN examples under non implanted VNS Added new ICD-10-CM diagnosis codes G43.E01-G43.E19 for migraine (end of range) | 10/1/2023 | MED.00140 Lentiviral Gene Therapy for Beta Thalassemia and Sickle Cell Disease Previously Titled: Gene Therapy for Beta Thalassemia" | • Revised title • Added INV&NMN statement on lovotibeglogene autotemcel Added ICD-10-PCS codes XW133H9, XW143H9 effective 10/1/2023 for transfusion of Lentiglobin, considered INV&NMN; no specific HCPCS codes for Lentiglobin, NOC codes already listed; removed ICD-10-PCS codes 30233C0, 30243C0 no longer applicable | 3/1/2024 | LAB.00040 Serum Biomarker Tests for Risk of Preeclampsia | Added existing CPT PLA code 0390Ufor PEPredictDx test, considered INV&NMN | 3/1/2024 | LAB.00028 Blood-based Biomarker Tests for Multiple Sclerosis Previously titled: Serum Biomarker Tests for Multiple Sclerosis" | • Revised title • Expanded scope of document from serum to blood-based biomarker testing for multiple sclerosis (MS) • Revised Position Statement to indicate blood-based biomarker tests for multiple sclerosis are considered INV&NMN for all uses Added existing CPT PLA code 0361U for Neurofilament Light Chain test, considered INV&NMN | 3/1/2024 | LAB.00011 Selected Protein Biomarker Algorithmic Assays | • Reformatted bullet points to letters • Added IMMray® PanCan-d test to the INV&NMN statement Added existing CPT PLA code 0342U for IMMray test, considered INV&NMN | 3/1/2024 | DME.00049 External Upper Limb Stimulation for the Treatment of Tremors | • Revised Position Statement to include INV&NMN for Parkinson’s | 9/27/2023 | DME.00043 Neuromuscular Electrical Training for the Treatment of Obstructive Sleep Apnea or Snoring | Added HCPCS codes E0490, E0491 effective 10/01/2023 for device with hardware remote, considered INV&NMN | 3/1/2024 | DME.00041 Ultrasonic Diathermy Devices | Added HCPCS code K1036 effective 10/01/2023 for device supplies and accessories, considered INV&NMN | 3/1/2024 | DME.00011 Electrical Stimulation as a Treatment for Pain and Other Conditions: Surface and Percutaneous Devices | • Reformatted bullet points to letters • Added lines to INV&NMN statement on electrical stimulation wound treatment device, electromagnetic wound treatment devices and pulsed electromagnetic field stimulation Added existing HCPCS code E0769 for electromagnetic wound devices, considered INV&NMN | 3/1/2024 | CG-SURG-97 Cardioverter Defibrillators | Added new ICD-10-CM code I21.B effective 10/01/2023 to end of range | 10/1/2023 | CG-SURG-83 Bariatric Surgery and Other Treatments for Clinically Severe Obesity | • Added criteria regarding BMI parameters, pre-operative evaluations and education and treatment plans and removed criteria regarding % weight loss amounts and compliance evaluation for revision/conversion indications • Removed NMN statement regarding stomach stretching and overeating" | 9/27/2023 | CG-SURG-63 Cardiac Resynchronization Therapy with or without an Implantable Cardioverter Defibrillator for the Treatment of Heart Failure | Added new ICD-10-CM code I21.B to end of range | 10/1/2023 | CG-MED-83 Site of Care: Specialty Pharmaceuticals | • Revised formatting in Clinical Indications section • Added new MN statement addressing geographic accessibility" | 9/27/2023 | ANC.00009 "Cosmetic and Reconstructive Services of the Trunk, Groin, and Extremities Previously titled: Cosmetic and Reconstructive Services of the Trunk and Groin" | • Revised title to include “Extremities"" • Revised Position Statement regarding lipectomy or liposuction for lymphedema and lipedema" | 3/1/2024 | CG-GENE-14 Gene Mutation Testing for Cancer Susceptibility and Management | • Revised section “B Gene Mutation Testing to Guide Targeted Cancer Therapy” and section "C Circulating Tumor DNA (liquid biopsy)" to include cancer management in the Clinical Indications section | 9/27/2023 | LAB.00029 Rupture of Membranes Testing in Pregnancy | Removed CPT PLA code 0066U for PartoSure test. | 9/27/2023 |
Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-044676-23 Medical Policy & Clinical Guidelines | Commercial | December 1, 2023 Notice of Material Amendments to Contract and/or Change to Prior Authorization Requirements Medical Policies and Clinical Guidelines updates — December 2023The following Anthem Blue Cross and Blue Shield (Anthem) Medical Policies and Clinical Guidelines were reviewed for Indiana, Kentucky, Missouri, Ohio, and Wisconsin. To view Medical Policies and Utilization Management Guidelines, go to anthem.com. Select Providers, then select your state. Under Provider Resources, select Policies, Guidelines & Manuals. To help determine if prior authorization (PA) is needed for Anthem members, go to anthem.com. Select Providers, then select your state. Under Claims, select Prior Authorization. You can also call the prior authorization phone number on the back of the member’s ID card. To view Medical Policies and Utilization Management Guidelines applicable to members enrolled in the Blue Cross and Blue Shield Service Benefit Plan (commonly referred to as the Federal Employee Program®), visit fepblue.org and select Policies & Guidelines. Below are the current Clinical Guidelines and/or Medical Policies that were reviewed, updated, and approved. Policy/guideline | Information | Effective date | MED.00002 Selected Sleep Testing Services | Add to PA | 3/1/2024 | MED.00011 Sensory Stimulation for Brain-Injured Individuals in Coma or Vegetative State | Add to PA | 3/1/2024 | MED.00024 Adoptive Immunotherapy and Cellular Therapy | Add to PA | 3/1/2024 | MED.00082 Quantitative Sensory Testing | Add to PA | 3/1/2024 | MED.00092 Automated Nerve Conduction Testing | Add to PA | 3/1/2024 | MED.00096 Low-Frequency Ultrasound Therapy for Wound Management | Add to PA | 3/1/2024 | MED.00098 Hyperoxemic Reperfusion Therapy | Add to PA | 3/1/2024 | MED.00101 Physiologic Recording of Tremor using Accelerometer(s) and Gyroscope(s) | Add to PA | 3/1/2024 | MED.00103 Automated Evacuation of Meibomian Gland | Add to PA | 3/1/2024 | MED.00105 Bioimpedance Spectroscopy Devices for the Detection and Management of Lymphedema | Add to PA | 3/1/2024 | MED.00111 Intracardiac Ischemia Monitoring | Add to PA | 3/1/2024 | MED.00115 Outpatient Cardiac Hemodynamic Monitoring Using a Wireless Sensor for Heart Failure Management | Add to PA | 3/1/2024 | MED.00125 Biofeedback and Neurofeedback | Add to PA | 3/1/2024 | MED.00131 Electronic Home Visual Field Monitoring | Add to PA | 3/1/2024 | MED.00132 Adipose-derived Regenerative Cell Therapy and Soft Tissue Augmentation Procedures | Add to PA | 3/1/2024 | MED.00134 Non-invasive Heart Failure and Arrhythmia Management and Monitoring System | Add to PA | 3/1/2024 | MED.00137 Eye Movement Analysis Using Non-Spatial Calibration for the Diagnosis of Concussion | Add to PA | 3/1/2024 | MED.00141 High-volume Colonic Irrigation | Add to PA | 3/1/2024 | RAD.00053 Cervical and Thoracic Discography | Add to PA | 3/1/2024 |
Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-038928-23 Anthem Blue Cross and Blue Shield (Anthem) wants to help ensure that members have access to medications with evidence to improve health and promote evidence-based, clinically appropriate use that align with FDA prescribing guidelines. While Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists have gained popularity because of their weight loss effects, they are currently FDA-approved for diabetes only. Wegovy® and Saxenda® are FDA-approved for weight loss only and not for treatment of diabetes. For the most part, our member benefits specifically exclude weight loss drugs, yet GLP-1 Receptor Agonists approved only for diabetes are being used off-label for weight loss and contributing to clinically inappropriate use. Compliance with prescribing guidelines is a requirement of Anthem network participation. Beginning January 1, 2024, we will require verification of diagnosis of diabetes for Medicare members. GLP-1 Agents (Adlyxin, Bydureon, Byetta, Ozempic, Rybelsus, Trulicity, Victoza) requests may be approved based on the following criteria: - Individual has a diagnosis of type 2 diabetes; AND
- Written documentation has been provided that diagnosis has been verified by history of:
- Hemoglobin A1c (A1C) greater than or equal to 6.5%; OR
- Fasting Plasma Glucose (FPG) greater than or equal to 126 mg/dl (after fasting for at least 8 hours); OR
- Two-hour plasma glucose greater than or equal to 200mg/dl as part of an oral glucose tolerance test (75g oral glucose after fasting for at least 8 hours); OR
- Symptoms of hyperglycemia (including polyuria, polydipsia, polyphagia) or hyperglycemic crisis and a random plasma glucose greater than or equal to 200 mg/dl; AND
- Glucagon-like peptide-1 (GLP-1) receptor agonist may not be approved for the following:
- Weight loss {CMS exclusion}
You can access our drug lists and formulary policies by visiting Pharmacy Information for Providers | Anthem.com. Scroll down to Drug List Management and select Drug List Selection (anthem.com). Here you will be able to search for the policies based on the member’s health plan. If you have questions, please contact Provider Services. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-043752-23-CPN42761 Effective April 1, 2024, Anthem Blue Cross and Blue Shield will transition to the following genetic testing guidelines for Carelon Medical Benefits Management, Inc. to perform medical necessity/clinical appropriateness reviews for requested genetic tests. Applicable CPT® codes lists are included in each guideline linked below: Prior authorization requirements remain the same. The requested services received on or after April 1, 2024, will be reviewed with the new Clinical Criteria. As a reminder, ordering and servicing providers may submit prior authorization requests directly to the ProviderPortalSM for Carelon Medical Benefits Management directly at providerportal.com. Online access is available 24/7 to process orders in real-time and is the fastest and most convenient way to request authorization. For questions related to guidelines, please contact Carelon Medical Benefits Management via email at MedicalBenefitsManagement.guidelines@Carelon.com. Additionally, you may access and download a copy of the current and upcoming guidelines here. Carelon Medical Benefits Management, Inc. is an independent company providing utilization management services on behalf of the health plan. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CR-041222-23-CPN40797 Medical Policy & Clinical Guidelines | Commercial | October 27, 2023 Notice of Material Amendments to Contract and/or Change to Prior Authorization Requirements Transition to Carelon Medical Benefits Management, Inc. Genetic Testing GuidelinesEffective April 1, 2024, Anthem Blue Cross and Blue Shield will transition to the following Carelon Medical Benefits Management, Inc.* Genetic Testing guidelines to perform medical necessity/clinical appropriateness reviews for requested genetic tests. Applicable CPT® codes lists are included in each guideline linked below: Prior authorization requirements remain the same. The requested services received on or after March 30, 2024, will be reviewed with the new Clinical Criteria. As a reminder, ordering and servicing providers may submit prior authorization requests to Carelon Medical Benefits Management using the following: - Carelon Medical Benefits Management ProviderPortalSM directly at providerportal.com. Online access is available 24/7 to process orders in real-time and is the fastest and most convenient way to request authorization.
If you have questions related to guidelines, please contact Carelon Medical Benefits Management via email at MedicalBenefitsManagement.guidelines@Carelon.com. Additionally, you may access and download a copy of the current and upcoming guidelines here. *Carelon Medical Benefits Management, Inc. is an independent company providing administrative support services on behalf of the health plan. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-038769-23-CPN38533 Prior authorization updates for medications billed under the medical benefit Effective on December 1, 2023, the following medication codes billed on medical claims from current or new Clinical Criteria documents will require prior authorization. Inclusion of a national drug code on your medical claim is necessary for claims processing. Visit the Clinical Criteria website to search for the specific Clinical Criteria listed below. Clinical Criteria | HCPCS or CPT® code(s) | Drug name | CC-0062 | J3490, Q5131 | Idacio (adalimumab-aacf) |
What if I need assistance?If you have questions about this communication or need assistance with any other item, contact your local provider relationship management representative or call Provider Services at 844-912-1226. Note: Prior authorization requests for certain medications may require additional documentation to determine medical necessity. Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-040838-23-CPN40471 Effective January 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem Blue Cross and Blue Shield for Medicaid members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these PA rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Refer to attachment to view full details Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-043819-23-CPN43761 ATTACHMENTS (available on web): Prior authorization requirement changes effective January 1, 2024 (pdf - 0.13mb) UPDATE: This article was originally published as being effective March 1, 2024. The effective date has been delayed to May 1, 2024. Effective May 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem Blue Cross and Blue Shield for Medicare members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Description | 0738T | Treatment planning for magnetic field induction ablation of malignant prostate tissue, using data from previously performed magnetic resonance imaging (MRI) examination | 0739T | Ablation of malignant prostate tissue by magnetic field induction, including all intraprocedural, transperineal needle/catheter placement for nanoparticle installation and int |
Not all PA requirements are listed here. Detailed PA requirements are available to providers on anthem.com/medicareprovider on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call the number on the back of their patient’s member ID card .for assistance with PA requirements. UM AROW #: A2023M0443 Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-044235-23-CPN43832, CPN-CRMMP-049296-24 UPDATE: This article was originally published as being effective March 1, 2024. The effective date has been delayed to May 1, 2024. Effective May 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem Blue Cross and Blue Shield for Medicare members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Description | Q4272 | Esano a, per square centimeter | Q4273 | Esano aaa, per square centimeter | Q4274 | Esano ac, per square centimeter | Q4275 | Esano aca, per square centimeter | Q4276 | Orion, per square centimeter | Q4277 | Woundplus membrane or e-graft, per square centimeter | Q4278 | Epieffect, per square centimeter | Q4280 | Xcell amnio matrix, per square centimeter | Q4281 | Barrera sl or barrera dl, per square centimeter | Q4282 | Cygnus dual, per square centimeter | Q4283 | Biovance tri-layer or biovance 3l, per square centimeter | Q4284 | Dermabind sl, per square centimeter |
Not all PA requirements are listed here. Detailed PA requirements are available to providers on anthem.com/medicareprovider on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call the number on the back of their patient’s member ID card .for assistance with PA requirements. UM AROW #: A2023M0417 Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-044198-23-CPN43849, CPN-CRMMP-049296-24 UPDATE: This article was originally published as being effective March 1, 2024. The effective date has been delayed to May 1, 2024. Effective May 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA for Anthem Blue Cross and Blue Shield members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Description | E0761 | Non-Thermal Pulsed High Frequency Radiowaves, High Peak Power Electrom |
Not all PA requirements are listed here. Detailed PA requirements are available to providers on anthem.com/medicareprovider on the Resources tab or for contracted providers by accessing Availity.com. Providers may also call the number on the back of their patient’s member ID card for Provider Services. UM AROW #: A2023M0415 Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-044184-23-CPN43845, CPN-CRMMP-049296-24 Effective March 1, 2024, prior authorization (PA) requirements will change for the following code(s). The medical code(s) listed below will require PA by Anthem Blue Cross and Blue Shield for Medicare members. Federal and state law, as well as state contract language and Centers for Medicare & Medicaid Services guidelines, including definitions and specific contract provisions/exclusions take precedence over these precertification rules and must be considered first when determining coverage. Non-compliance with new requirements may result in denied claims. Prior authorization requirements will be added for the following code(s): Code | Description | 33275 | Transcatheter removal of permanent leadless pacemaker, right ventricular | 33274 | Transcatheter insertion or replacement of permanent leadless pacemaker, right ventricular, including imaging guidance (such as fluoroscopy, venous ultrasound, ventriculography, femoral venography) and device evaluation (such as interrogation or programming), when performed |
Not all PA requirements are listed here. Detailed PA requirements are available to providers by visiting Medicare Advantage Providers | Anthem.com > Providers > Claims> Prior Authorization, or for contracted providers by accessing Availity.com. Providers may also call number on the back of their patient’s member ID card for Provider Service for assistance with PA requirements. UM AROW 4290 Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CR-042748-23-CPN41430 Anthem Blue Cross and Blue Shield (Anthem) is excited to announce a new High Performing Provider (HPP) designation to care providers meeting certain cost and quality metrics. Through this new designation, Anthem is expanding our consumer tools and content to assist members in making more informed and personalized healthcare decisions. Initially, the designation will focus on certain types of professional providers, but it may be broadened to include other care provider types in the future. The High Performing Provider designation will launch on January 1, 2024. Anthem may highlight HPPs in various ways, including, but not limited to: - Special opportunities to participate in product offerings.
- When members contact Anthem with requests for referral options.
- Placing a designation in Anthem’s Care and Cost Finder. This would be in addition to Anthem’s existing tool in Care and Cost Finder called Personalized Match that provides Anthem members with the option to search for in-network care providers through a specialized sorting tool that considers certain cost and quality metrics, as well.
For more information on the HPP designation, you can view the designation methodology, or to know if your practice will receive the designation, send an email to HPPdesignation@anthem.com. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-045688-23-CPN44770, MULTI-BCBS-CM-045690-23-CPN44770 ATTACHMENTS (available on web): designation methodology (pdf - 0.15mb) The Federal Employee Program® (FEP) will now be issuing ID cards at the member level. These cards will be issued based on the member’s plan coverage. To implement this change, FEP is sending updated member ID cards in the fall of 2023 and early 2024. Members who have not received their new ID card yet can continue to use their existing ID cards until the new ID card is received. For further information regarding our new Member ID cards, contact the FEP Customer Service number on the back of the member’s ID card. Also new for 2024Starting January 1, 2024, FEP will offer a new prescription drug benefit called FEP Medicare Prescription Drug Program (MPDP). MPDP is an optional prescription drug benefit available for members who are Medicare eligible, and part of the member’s plan coverage. For members enrolled in MPDP, their new ID card will display their MPDP ID number. Do not confuse this with the existing Member ID card. You will still need to use the Member ID for claims submissions. Make copies of all ID cards for your records. Please note members can disenroll from or enroll in MPDP later, and their information could change. Below is a sample of the new Member ID card with MPDP enrollment.
The following instructions still apply when submitting claims: - Use a valid member ID number.
- Include the patient’s first and last name.
- Name the health plan policy owner (insured) who is responsible for the policy.
For further information regarding our new Member ID cards or MPDP, contact the FEP Customer Service number on the back of the member’s ID card. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-044861-23 To view the 2024 benefits and changes for the Federal Employee Program® (FEP), go to Fepblue.org and select Tools and Resources, then select Brochure and Resources. Here you will find the Service Benefit Plan Brochure, Benefit Plan Summaries, and Quick Reference Guides on information for 2024. If you have questions, contact FEP customer service at CO – 800-852-5957 CT – 800-438-5356 GA – 800-282-2473 IN – 800-382-5520 KY – 800-456-3967 ME – 800-722-0203 MO – 800-392-8043 NV – 800-727-4060 NH – 800-852-3316 OH – 800-451-7602 VA – 800-552-6989 WI – 800-242-9635. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-043908-23-CPN43800 CarelonRx mail service pharmacy will change to CarelonRx Pharmacy on January 1, 2024. This pharmacy change does not affect the way CarelonRx works with care providers. There are no changes to the prior authorization process, how claims are processed, or level of support. This change does not impact your patients’ benefits, coverage, or how their medications are filled. When e-prescribing orders to the mail service pharmacy: - Prescribers will need to choose CarelonRx Pharmacy, not CarelonRx Mail, if searching by name.
- If searching by NPI (National Provider Identifier), the NPI is changing to 1568179489.
We are taking steps to ensure a smooth transition to our new home delivery pharmacy for your patients: - Patients will receive a letter to alert them of their new pharmacy.
- If a patient has refills left, we will move them to CarelonRx Pharmacy, and we’ll also transfer auto refills.
- If a patient doesn’t have any refills left of their medication(s), CarelonRx Pharmacy will contact you to obtain a new prescription.
- If a patient is taking a controlled substance, CarelonRx Pharmacy will contact you to obtain a new prescription.
- All prior authorizations will be transitioned to CarelonRx Pharmacy.
CarelonRx Pharmacy will deliver an enhanced, digital-first solution to your patients to improve adherence and lower costs, while removing barriers associated with traditional retail and mail order pharmacy models. Some highlights include: - 24/7 text or chat (digitally) directly with our pharmacists at any time.
- Enhanced end-to-end order status tracking from prescription order to delivery.
- Acceptance of coupons; auto apply manufactured discounts (e-voucher), if applicable.*
- Free delivery of their 90-day supply, directly to a patient’s door.
* Not available for Medicare or Medicaid patients. CarelonRx, Inc. is an independent company providing pharmacy benefit management services on behalf of the health plan. Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CM-045616-23-CPN45533 Visit the Drug Lists page on our provider website at https://www.anthem.com/ms/pharmacyinformation/home.html for more information about: - Copayment/coinsurance requirements and their applicable drug classes.
- Drug lists and changes.
- Prior authorization criteria.
- Procedures for generic substitution.
- Therapeutic interchange.
- Step therapy or other management methods subject to prescribing decisions.
- Any other requirements, restrictions, or limitations that apply to using certain drugs.
The commercial and exchange drug lists are posted to the website quarterly on the first day of the month in January, April, July, and October. To locate the exchange, select Formulary and Pharmacy Information, and scroll down to Select Drug Lists. This drug list is also reviewed and updated regularly as needed. Federal Employee Program pharmacy updates and other pharmacy related information may be accessed at www.fepblue.org > Pharmacy Benefits. MULTI-BCBS-CM-018448-23, MULTI-BCBS-CM-041071-23-CPN41054, MULTI-BCBS-CM-044369-23-CPN44369 Effective for dates of service on and after December 1, 2023, updated step criteria for Iron Agents found in Clinical Criteria document CC-0182 will be implemented. The preferred product list is being expanded. Please refer to the Clinical Criteria page for more information. Clinical UM Guidelines are publicly available on the care provider website. Visit the Clinical Criteria page to search for specific criteria. Clinical UM Guidelines | Preferred drug(s) | Nonpreferred drug(s) | CC-0182 | Feraheme (ferumoxytol) Ferrlecit (sodium ferric gluconate/sucrose complex) Infed (iron dextran) Venofer (iron sucrose) | Injectafer (ferric carboxymaltose) Monoferric (ferric derisomaltose) |
We’re committed to active involvement with our care provider partners and going beyond the contract to create a real impact on the health of our communities. MULTI-BCBS-CR-038913-23-CPN38505 HEDIS® measure data is collected by one or more methods: - Administrative method — claims and supplemental data
- Hybrid method — administrative and medical record data
- Survey method — Health Outcomes Survey(HOS) & Consumer Assessment of Healthcare Providers & Systems (CAHPS®)
- Electronic Clinical Data Systems (ECDS) — HEDIS reporting standard that leverages electronic data from multiple sources. See below.
The HEDIS Electronic Clinical Data Systems (ECDS) Reporting Standard was introduced in HEDIS 2016 (measurement year 2015) by the National Committee of Quality Assurance (NCQA) and encourages health information exchange, which is the secure sharing of patient medical information electronically. ECDS data collection is part of NCQA’s nationwide plan to capture information regarding aspects of care quality with less reliance on clinical medical record review. There are four types of ECDS: - Electronic Health Record (EHR)/Personal Health Record (PHR): Real-time, patient-centered records that make information available instantly and securely to authorized users. EHRs eligible for this category of ECDS reporting include the NCQA eMeasure certification program or any system that meets the 2015 Edition Base Electronic Health Record (EHR) definition.
- Health Information Exchange (HIE)/Clinical Registry: HIEs and clinical registries eligible for this reporting category include state HIEs, immunization information systems (IIS), public health agency systems, regional HIEs (RHIO), Patient-Centered Data Homes™ or other registries developed for research or to support quality improvement and patient safety initiatives. Doctors, nurses, pharmacists, other health care providers and patients can use HIEs to access and share vital medical information, with the goal of creating a complete patient record. Clinical registries can be sponsored by a government agency, nonprofit organization, health care facility or private company, and decisions regarding use of the data in the registry are the responsibility of the registry’s governing committee.
- Case Management System: A shared database of member information collected through a collaborative process of member assessment, care planning, care coordination or monitoring of a member’s functional status and care experience. Case management systems eligible for this category of ECDS reporting include any system developed to support the organization’s case/disease management activities, including activities performed by delegates.
- Administrative: Includes data from administrative claim processing systems for all services incurred (in other words, paid, suspended, pending and denied) during the period defined by each measure’s participation as well as member management files, member eligibility and enrollment files, electronic member rosters, internal audit files, and member call service databases.
Having more time to focus on patient care rather than responding to medical record requests is possible by participating in Electronic Clinical Data Systems (ECDS). We are focused on reducing administrative burdens, so you can do what you do best – care for our members. Let us help by granting EMR Direct Remote access to our EMR team. Need more information or ready to sign up? Please email us today at: Centralized_EMR_Team@unicare.com. HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). CAHPS® is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ). Anthem Blue Cross and Blue Shield Medicaid is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. OHBCBS-CD-041630-23-CPN41091 HEDIS® measure data is collected by one or more methods: - Administrative method — claims and supplemental data
- Hybrid method — administrative and medical record data
- Survey method — Health Outcomes Survey(HOS) & Consumer Assessment of Healthcare Providers & Systems (CAHPS®)
- Electronic Clinical Data Systems (ECDS) — HEDIS reporting standard that leverages electronic data from multiple sources. See below.
The HEDIS Electronic Clinical Data Systems (ECDS) Reporting Standard was introduced in HEDIS 2016 (measurement year 2015) by the National Committee of Quality Assurance (NCQA) and encourages health information exchange, which is the secure sharing of patient medical information electronically. ECDS data collection is part of NCQA’s nationwide plan to capture information regarding aspects of care quality with less reliance on clinical medical record review. There are four types of ECDS: - Electronic Health Record (EHR)/Personal Health Record (PHR): Real-time, patient-centered records that make information available instantly and securely to authorized users. EHRs eligible for this category of ECDS reporting include the NCQA eMeasure certification program or any system that meets the 2015 Edition Base Electronic Health Record (EHR) definition.
- Health Information Exchange (HIE)/Clinical Registry: HIEs and clinical registries eligible for this reporting category include state HIEs, immunization information systems (IIS), public health agency systems, regional HIEs (RHIO), Patient-Centered Data Homes™ or other registries developed for research or to support quality improvement and patient safety initiatives. Doctors, nurses, pharmacists, other health care providers and patients can use HIEs to access and share vital medical information, with the goal of creating a complete patient record. Clinical registries can be sponsored by a government agency, nonprofit organization, health care facility or private company, and decisions regarding use of the data in the registry are the responsibility of the registry’s governing committee.
- Case Management System: A shared database of member information collected through a collaborative process of member assessment, care planning, care coordination or monitoring of a member’s functional status and care experience. Case management systems eligible for this category of ECDS reporting include any system developed to support the organization’s case/disease management activities, including activities performed by delegates.
- Administrative: Includes data from administrative claim processing systems for all services incurred (in other words, paid, suspended, pending and denied) during the period defined by each measure’s participation as well as member management files, member eligibility and enrollment files, electronic member rosters, internal audit files, and member call service databases.
Having more time to focus on patient care rather than responding to medical record requests is possible by participating in Electronic Clinical Data Systems (ECDS). We are focused on reducing administrative burdens, so you can do what you do best – care for our members. Let us help by granting EMR Direct Remote access to our EMR team. Need more information or ready to sign up? Please email us today at: Centralized_EMR_Team@unicare.com. HEDIS® is a registered trademark of the National Committee for Quality Assurance (NCQA). CAHPS® is a registered trademark of the Agency for Healthcare Research and Quality (AHRQ). Anthem Blue Cross and Blue Shield is the trade name of Community Insurance Company. Independent licensee(s) of the Blue Cross Blue Shield Association. Anthem is a registered trademark of Anthem Insurance Companies, Inc. MULTI-BCBS-CRCM-041634-23-CPN41091 Anthem Blue Cross and Blue Shield (Anthem) has processes in place for our members under the age of 21 years old to ensure care that prevents, detects, and treats medical, social, educational, and other needs identified for our members. This care falls under our Early and Periodic Screening, Diagnostic, and Treatment (EPSDT) coverage. This program follows state guidelines of what care is recommended by age for eligible members to receive medical care, dental care, health screenings, mental health screenings, and social needs assessments and interventions. The EPSDT program uses internal reports to identify eligible members that are under 21 years of age. These reports identify members who are compliant with appropriate age care and those who have identified gaps in care. Anthem sends reminders to members for needed care and services offered, like transportation, to help the families and members who need connection to care. What does that mean for you as a care provider?Anthem will help connect members to you! We cover all the necessary appointments and needs for our members to keep wellness at the forefront for them and help break down barriers they face when getting the care they need. Anthem will use the data collected for our members and help direct them to you based on geographic location, care needs by age, and specialty. Anthem sends reminders, campaign information, and outreaches to members based on their preferences by text or email. For care providers who are part of our comprehensive maternal care (CMC), comprehensive primary care (CPC), and/or OhioRISE programs, we can help you set up access with direct communication through our care coordination portal (CCP) to make it easier with data sharing and digital communication. You can access this through the Care360 portal. If you do not have access, select the Go To OH|ID button to create an account. There are resources available for login help. We look forward to partnering with you. Anthem strives to be the bridge between the member and you, as their care provider. For general concerns, contact Member Services at 844-912-0938, or call 844-912-1226 for authorizations, claims, or any other billing needs. |